Terms: = Prostate cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Staging
5 results:
1. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
Liu Y; Qin Z; Yang K; Liu R; Xu Y
Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
[TBL] [Abstract] [Full Text] [Related]
2. Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in prostate cancer.
Chakravarthi BV; Goswami MT; Pathi SS; Dodson M; Chandrashekar DS; Agarwal S; Nepal S; Hodigere Balasubramanya SA; Siddiqui J; Lonigro RJ; Chinnaiyan AM; Kunju LP; Palanisamy N; Varambally S
Prostate; 2017 Jan; 77(1):10-21. PubMed ID: 27550065
[TBL] [Abstract] [Full Text] [Related]
3. AKT1 and myc induce distinctive metabolic fingerprints in human prostate cancer.
Priolo C; Pyne S; Rose J; Regan ER; Zadra G; Photopoulos C; Cacciatore S; Schultz D; Scaglia N; McDunn J; De Marzo AM; Loda M
Cancer Res; 2014 Dec; 74(24):7198-204. PubMed ID: 25322691
[TBL] [Abstract] [Full Text] [Related]
4. Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer.
Ishkanian AS; Zafarana G; Thoms J; Bristow RG
Acta Oncol; 2010 Oct; 49(7):888-94. PubMed ID: 20590366
[TBL] [Abstract] [Full Text] [Related]
5. Relationship of NKX3.1 and myc gene copy number ratio and DNA hypomethylation to prostate carcinoma stage.
Kindich R; Florl AR; Kamradt J; Lehmann J; Müller M; Wullich B; Schulz WA
Eur Urol; 2006 Jan; 49(1):169-75; discussion 175. PubMed ID: 16310933
[TBL] [Abstract] [Full Text] [Related]
